Journal of Cancer Education

, 23:214 | Cite as

Feasibility of an ovarian cancer quality-of-life psychoeducational intervention

  • Shirley Otis-Green
  • Betty Ferrell
  • Virginia Sun
  • Maren Spolum
  • Robert Morgan
  • Deborah MacDonald


Background. Diagnosis of ovarian cancer often portends a poor prognosis with significant quality-of-life (QOL) concerns. Method. We report on a pilot study that tested the feasibility of a structured, ovarian cancer psychoeducational intervention (OCPI). Patients (N=33) were randomly assigned to either the control or OCPI study arms in which those in the intervention arm received 4 sequential, structured, in-person educational sessions. Data were collected at the time of accrual and at 1 and 3 months postaccrual. Results. This study demonstrated the feasibility of a structured psychoeducational program in an outpatient clinical setting. Conclusion. Study findings underscore the importance of developing interventions that address the 4 QOL domains impacted by ovarian cancer and support initiating a comprehensive psychoeducational intervention earlier in the course of illness.


  1. 1.
    Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2007. CA Cancer J Clin. 2007:57:43–66.CrossRefPubMedGoogle Scholar
  2. 2.
    Markman M. Management of ovarian cancer. An impressive history improvement in survival and quality of life. Oncology (Williston Park) 2006;20:347–354; 357–358, 364.Google Scholar
  3. 3.
    Jemal A, Murray T, Samuels A, et al. Cancer Statistics, 2003. CA Cancer J Clin. 2003;53:5–26.CrossRefPubMedGoogle Scholar
  4. 4.
    McQuellon RP, Loggie BW, Lehman AB, et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol. 2003;10:155–162.CrossRefPubMedGoogle Scholar
  5. 5.
    Wenzel LB, Huang HQ, Armstrong DK, et al. Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:437–443.CrossRefPubMedGoogle Scholar
  6. 6.
    Hess L, Alberts D. The role of intraperitoneal therapy in advanced ovarian cancer. Oncology 2007;21:227–232.PubMedGoogle Scholar
  7. 7.
    Armstrong DK, Brady MF. Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time. J Clin Oncol. 2006;24:4531–4533.CrossRefPubMedGoogle Scholar
  8. 8.
    Ferrell BR, Smith SL, Cullinane CA, et al. Psychological well being and quality of life in ovarian cancer survivors. Cancer. 2003b;98:1061–1071.CrossRefPubMedGoogle Scholar
  9. 9.
    Howell D, Fitch MI, Deane KA. Women’s experiences with recurrent ovarian cancer. Cancer Nurs. 2003;26:10–17.CrossRefPubMedGoogle Scholar
  10. 10.
    Maughan K. Specific keynote: in the shadow of illness-supporting women with ovarian cancer. Gynecol Oncol. 2003;88(pt 2):S129-S133, S134–S135.CrossRefPubMedGoogle Scholar
  11. 11.
    Swenson MM, MacLeod JS, Williams SD, et al. Quality of living among ovarian germ cell cancer survivors: a narrative analysis. Oncol Nurs Forum [serial online]. 2003;30(3):380. Available from: Oncology Nursing Society: November 4, 2008.Google Scholar
  12. 12.
    Wenzel LB, Donnelly JP, Fowler JM, et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psycho-oncology 2002;11:142–153.CrossRefPubMedGoogle Scholar
  13. 13.
    Tannock IF, Ahles TA, Ganz PA, et al. Cognitive impairments associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004;22:2233–2239.CrossRefPubMedGoogle Scholar
  14. 14.
    Doyle C, Crump M, Pintilie M, et al. Does palliative chemotherapy palliated: evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol. 2001;19:1266–1274.PubMedGoogle Scholar
  15. 15.
    Lakusta CM, Atkinson MJ, Robinson JW, et al. Quality of life in ovarian cancer patients receiving chemotherapy. Gynecol Oncol. 2001;81:490–495.CrossRefPubMedGoogle Scholar
  16. 16.
    Fitch MI, Gray RE, Franssen E. Women’s perspectives regarding the impact of ovarian cancer: implications for nursing. Cancer Nurs. 2000;23:359–366.CrossRefPubMedGoogle Scholar
  17. 17.
    Ferrell BR, Smith SL, Cullinane CA, et al. Symptom concerns of women with ovarian cancer. J Pain Symptom Manage. 2003a; 25:528–538CrossRefPubMedGoogle Scholar
  18. 18.
    Ersek M, Ferrell BR, Dow KH, et al. Quality of life in women with ovarian cancer. West J Nurs Res. 1997;19:334–350.CrossRefPubMedGoogle Scholar
  19. 19.
    Anderson B. Quality of life in progressive ovarian cancer. Gynecol Oncol. 1994;55 (Pt 2):S151-S155.PubMedGoogle Scholar
  20. 20.
    Carroll-Johnson RM, Gorman LM, Bush NJ. Psychological Nursing Care Along the Cancer Continuum. Pittsburgh, PA: Oncology Nursing Press; 1998.Google Scholar
  21. 21.
    Hamilton AB. Psychological aspects of ovarian cancer. Cancer Invest, 1999;17:335–341.CrossRefPubMedGoogle Scholar
  22. 22.
    National Institute of Health. Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol. 1994;55(pt 2):S4-S14.Google Scholar
  23. 23.
    Lutgendorf SK, Anderson B, Ullrich P, et al. Quality of life and mood in women with gynecologic cancer: a one year prospective study. Cancer. 2002;94:131–140.CrossRefPubMedGoogle Scholar
  24. 24.
    Houck K, Avis NE, Gallant JM, et al. Quality of life in advanced ovarian cancer: identifying specific concerns. J Palliat Med. 1999;2:397–402.CrossRefPubMedGoogle Scholar
  25. 25.
    Weitzel J, MacDonald, DJ. Genetic testing for ovarian cancer. Qual Life Res. 1998;6:101–108.Google Scholar
  26. 26.
    Di Prospero LS, Seminsky M, Honeyford J, et al. Psychosocial issues-following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. Can Med Assoc J. 2001;164:1005–1009.Google Scholar
  27. 27.
    Ferrell BR, Grant M, Funk B, et al. Quality of life in breast cancer survivors: implications for developing support services. Oncol Nurs Forum. 1998;25:887–895.PubMedGoogle Scholar
  28. 28.
    Ferrell BR, Grant M, Funk B, et al. Quality of life in breast cancer survivors as identified by focus groups. Psycho-oncology. 1997;6:13–23.CrossRefPubMedGoogle Scholar
  29. 29.
    Hallowell N. A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. Psycho-oncology. 2000;9:486–495.CrossRefPubMedGoogle Scholar
  30. 30.
    Meiser B, Tiller K, Glesson MA, et al. Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer. Psycho-oncology. 2000;9:496–503.CrossRefPubMedGoogle Scholar
  31. 31.
    Ferrell BR, Grant M, Funk B, et al. Quality of life in breast cancer. Part II: psychological and spiritual well being. Cancer Nurs 1997;21:1–9.Google Scholar
  32. 32.
    Kemp C. Spiritual care interventions. In: Ferrell B, Coyle N, eds. Textbook of Palliative Nursing. New York, NY: Oxford University Press;2001:407–414.Google Scholar
  33. 33.
    Brown-Saltzman KA. Tending the spirit. Oncol Nurs Forum. 1994;21:1001–1006.PubMedGoogle Scholar
  34. 34.
    Burton LA. The spiritual dimension of palliative care. Semin Oncol Nurs. 1998;14:121–128.CrossRefPubMedGoogle Scholar
  35. 35.
    Dow KH, Ferrell BR, Haberman MR, et al. The meaning of quality of life in cancer survivorship. Oncol Nurs Forum 1999;26:519–528.PubMedGoogle Scholar
  36. 36.
    Ferrell BR, Smith SL, Juarez G, et al. Meaning of illness and spirituality in ovarian cancer survivors. Oncol Nurs Forum 2003d;30(2):249–257.CrossRefPubMedGoogle Scholar
  37. 37.
    Payne DK, Massie MJ. Depression and anxiety. In: Berger A, Portenoy RK, Weisman DE, eds. Supportive Oncology: Philadelphia, PA: Lippencott-Raven; 1998:497–512.Google Scholar
  38. 38.
    Fry A, Busby-Earle C, Rush R, et al. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer. Psycho-oncology 2001;10:231–241.CrossRefPubMedGoogle Scholar
  39. 39.
    Hughes C, Lerman C, Schwartz M, et al. All in the family: evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet. 2002;107:143–150.CrossRefPubMedGoogle Scholar
  40. 40.
    Ferrell BR, Smith SL, Ervin KS, et al. A qualitative analysis of social concerns of women with ovarian cancer. Psycho-oncology. 2003c;12:647–663.CrossRefPubMedGoogle Scholar
  41. 41.
    Ferrell BR, Cullinane CA, Ervine K, et al. Perspectives on the impact of ovarian cancer: women’s views of quality of life. Oncol Nurs Forum. 2005;32(6):1143–1149.CrossRefPubMedGoogle Scholar
  42. 42.
    Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res 1995;4:523–531.CrossRefPubMedGoogle Scholar
  43. 43.
    Mishel MH, Sorenson DS. Uncertainty in gynecological cancer: a test of the mediating functions of mastery and coping. Nurs Res. 1991;40:167–171.PubMedGoogle Scholar
  44. 44.
    Donovan KA, Jacobsen PB, Holland JC, et al. Psychometric properties and correlates of Distress Thermometer Scores. Psycho-oncology. 2004;13:S16.Google Scholar
  45. 45.
    Mishel MH. The measurement of uncertainty in illness. Nurs Res. 1981;30:258–263.CrossRefPubMedGoogle Scholar
  46. 46.
    Mishel MH. Uncertainty in illness. Image J Nurs Sch. 1988;20:225–232.CrossRefPubMedGoogle Scholar
  47. 47.
    Mishel MH, Braden CJ. Finding meaning: antecedents of uncertainty in illness. Nurs Res. 1988;37:98–103.CrossRefPubMedGoogle Scholar
  48. 48.
    Mishel M. Uncertainty in Illness Scales Manual. Chapel Hill, NC: University of North Carolina; 1997.Google Scholar

Copyright information

© American Association for Cancer Education 2008

Authors and Affiliations

  • Shirley Otis-Green
    • 1
  • Betty Ferrell
    • 1
  • Virginia Sun
    • 1
  • Maren Spolum
    • 1
  • Robert Morgan
    • 1
  • Deborah MacDonald
    • 1
  1. 1.City of Hope National Medical CenterNursing Research and EducationDuarte

Personalised recommendations